167 related articles for article (PubMed ID: 38843294)
1. Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.
Hilgendorf I; Frantz S; Frangogiannis NG
Circ Res; 2024 Jun; 134(12):1718-1751. PubMed ID: 38843294
[TBL] [Abstract][Full Text] [Related]
2. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
Prabhu SD; Frangogiannis NG
Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
[TBL] [Abstract][Full Text] [Related]
3. Fibroblasts in myocardial infarction: a role in inflammation and repair.
Shinde AV; Frangogiannis NG
J Mol Cell Cardiol; 2014 May; 70():74-82. PubMed ID: 24321195
[TBL] [Abstract][Full Text] [Related]
4. The immune system and cardiac repair.
Frangogiannis NG
Pharmacol Res; 2008 Aug; 58(2):88-111. PubMed ID: 18620057
[TBL] [Abstract][Full Text] [Related]
5. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
6. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.
Dobaczewski M; de Haan JJ; Frangogiannis NG
J Cardiovasc Transl Res; 2012 Dec; 5(6):837-47. PubMed ID: 22956156
[TBL] [Abstract][Full Text] [Related]
7. Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction.
Venugopal H; Hanna A; Humeres C; Frangogiannis NG
Cells; 2022 Apr; 11(9):. PubMed ID: 35563692
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction.
Alex L; Tuleta I; Hernandez SC; Hanna A; Venugopal H; Astorkia M; Humeres C; Kubota A; Su K; Zheng D; Frangogiannis NG
Circulation; 2023 Sep; 148(11):882-898. PubMed ID: 37350296
[TBL] [Abstract][Full Text] [Related]
9. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling.
Bujak M; Dobaczewski M; Chatila K; Mendoza LH; Li N; Reddy A; Frangogiannis NG
Am J Pathol; 2008 Jul; 173(1):57-67. PubMed ID: 18535174
[TBL] [Abstract][Full Text] [Related]
11. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.
Frangogiannis NG
J Cardiovasc Pharmacol; 2014 Mar; 63(3):185-95. PubMed ID: 24072174
[TBL] [Abstract][Full Text] [Related]
12. Cardiac fibrosis.
Frangogiannis NG
Cardiovasc Res; 2021 May; 117(6):1450-1488. PubMed ID: 33135058
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of Myocardial Infarction.
Frangogiannis NG
Compr Physiol; 2015 Sep; 5(4):1841-75. PubMed ID: 26426469
[TBL] [Abstract][Full Text] [Related]
14. Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium.
Kong P; Shinde AV; Su Y; Russo I; Chen B; Saxena A; Conway SJ; Graff JM; Frangogiannis NG
Circulation; 2018 Feb; 137(7):707-724. PubMed ID: 29229611
[TBL] [Abstract][Full Text] [Related]
15. Targeting the inflammatory response in healing myocardial infarcts.
Frangogiannis NG
Curr Med Chem; 2006; 13(16):1877-93. PubMed ID: 16842199
[TBL] [Abstract][Full Text] [Related]
16. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.
Cochain C; Auvynet C; Poupel L; Vilar J; Dumeau E; Richart A; Récalde A; Zouggari Y; Yin KY; Bruneval P; Renault G; Marchiol C; Bonnin P; Lévy B; Bonecchi R; Locati M; Combadière C; Silvestre JS
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2206-13. PubMed ID: 22796582
[TBL] [Abstract][Full Text] [Related]
17. Pericytes in the infarcted heart.
Alex L; Frangogiannis NG
Vasc Biol; 2019; 1(1):H23-H31. PubMed ID: 32923950
[TBL] [Abstract][Full Text] [Related]
18. TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities.
Frangogiannis NG
Expert Opin Ther Targets; 2024; 28(1-2):45-56. PubMed ID: 38329809
[TBL] [Abstract][Full Text] [Related]
19. Macrophages in myocardial infarction.
Kubota A; Frangogiannis NG
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1304-C1324. PubMed ID: 36094436
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory mechanisms in myocardial infarction.
Ren G; Dewald O; Frangogiannis NG
Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):242-56. PubMed ID: 14561159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
